| |
HC (n = 20)
|
AFB-positive TB patients (n = 20)
|
|---|
|
Age (years)
|
45 ± 21.9 (22–76)
|
55 ± 19.8 (18–86)
|
|
Sex (m/f)
|
12/8
|
13/7
|
|
Radiographic features
|
|
Infiltration
|
–
|
20/20 (100)
|
|
Cavitation
|
–
|
7/20(35)
|
|
Effusion
|
–
|
3/20 (15)
|
|
Smear grading
|
|
4+
|
–
|
5/20 (25)
|
|
3+
|
–
|
6/20 (30)
|
|
2+
|
–
|
5/20 (25)
|
|
1+
|
–
|
4/20 (20)
|
|
Resistance
|
–
|
–
|
|
Treatment
|
–
|
HREZa 20/20 (100)
|
-
aHERZ, isoniazid, ethambutol, rifampicin, plus pyrazinamide. Categorical variable data are presented as positive/tested (%). Continuous variable data are shown as mean ± SD (range)
